Ineffective implantable cardioverter-defibrillator shocks among patients on continuous left ventricular assist device support: Clinical characteristics and management.

Defibrillation threshold Implantable cardioverter-defibrillator Ineffective shocks Left ventricular assist device Ventricular arrhythmias

Journal

Heart rhythm O2
ISSN: 2666-5018
Titre abrégé: Heart Rhythm O2
Pays: United States
ID NLM: 101768511

Informations de publication

Date de publication:
Dec 2020
Historique:
entrez: 11 6 2021
pubmed: 12 6 2021
medline: 12 6 2021
Statut: epublish

Résumé

Placement of a left ventricular assist device (LVAD) has been described to compromise implantable cardioverter-defibrillator (ICD) defibrillation threshold (DFT). Elevated DFT will have negative consequences and increases the risk of ineffective ICD shocks, morbidity, and mortality. DFT testing is not routinely performed in clinical practice, despite this fact. We describe the clinical characteristics of 7 LVAD patients who presented with multiple ineffective ICD shocks, along with the management strategy in such patients. Seven patients (5 male, mean age 52.2 ± 9 years, 85.7% nonischemic cardiomyopathy) with an ICD in situ who progressed to NYHA class IV, ACC/AHA stage D chronic systolic congestive heart failure who underwent successful LVAD implantation presented to our institution in the setting of ventricular tachyarrhythmia and ineffective ICD shocks. Six patients underwent implantation of azygos and subclavian coils with subsequent DFT testing. The remaining patient was made comfort care. Five patients had successful DFT testing with azygos (n = 4) and subclavian (n = 1) defibrillation coil implantation. One patient had unsuccessful DFT testing despite evaluation of multiple shock vectors. There were no major or minor vascular complications in any of the cases. There were no procedural-related deaths. This case series highlights the need for a systematic approach to management of ICDs and DFT testing in LVAD patients. The addition of new shock vectors with azygos and subclavian coil implantation may reduce DFT, shock burden, morbidity, and mortality.

Sections du résumé

BACKGROUND BACKGROUND
Placement of a left ventricular assist device (LVAD) has been described to compromise implantable cardioverter-defibrillator (ICD) defibrillation threshold (DFT). Elevated DFT will have negative consequences and increases the risk of ineffective ICD shocks, morbidity, and mortality. DFT testing is not routinely performed in clinical practice, despite this fact.
OBJECTIVE OBJECTIVE
We describe the clinical characteristics of 7 LVAD patients who presented with multiple ineffective ICD shocks, along with the management strategy in such patients.
METHODS METHODS
Seven patients (5 male, mean age 52.2 ± 9 years, 85.7% nonischemic cardiomyopathy) with an ICD in situ who progressed to NYHA class IV, ACC/AHA stage D chronic systolic congestive heart failure who underwent successful LVAD implantation presented to our institution in the setting of ventricular tachyarrhythmia and ineffective ICD shocks. Six patients underwent implantation of azygos and subclavian coils with subsequent DFT testing. The remaining patient was made comfort care.
RESULTS RESULTS
Five patients had successful DFT testing with azygos (n = 4) and subclavian (n = 1) defibrillation coil implantation. One patient had unsuccessful DFT testing despite evaluation of multiple shock vectors. There were no major or minor vascular complications in any of the cases. There were no procedural-related deaths.
CONCLUSION CONCLUSIONS
This case series highlights the need for a systematic approach to management of ICDs and DFT testing in LVAD patients. The addition of new shock vectors with azygos and subclavian coil implantation may reduce DFT, shock burden, morbidity, and mortality.

Identifiants

pubmed: 34113891
doi: 10.1016/j.hroo.2020.11.001
pii: S2666-5018(20)30145-8
pmc: PMC8183971
doi:

Types de publication

Journal Article

Langues

eng

Pagination

336-340

Informations de copyright

© 2020 Heart Rhythm Society. Published by Elsevier Inc.

Références

Pacing Clin Electrophysiol. 2009 Jul;32(7):879-87
pubmed: 19572863
Pacing Clin Electrophysiol. 2012 May;35(5):e144-8
pubmed: 21679198
J Card Fail. 2012 Feb;18(2):140-5
pubmed: 22300782
Pacing Clin Electrophysiol. 2008 Oct;31(10):1246-52
pubmed: 18811803
Am J Cardiol. 2007 Apr 15;99(8):1151-3
pubmed: 17437746
J Am Coll Cardiol. 2005 May 3;45(9):1428-34
pubmed: 15862414
Pacing Clin Electrophysiol. 2014 Apr;37(4):464-72
pubmed: 24237034
J Card Fail. 2010 Apr;16(4):327-31
pubmed: 20350700
Eur J Heart Fail. 2010 Jun;12(6):593-9
pubmed: 20406799
J Heart Lung Transplant. 2014 Mar;33(3):318-20
pubmed: 24559946

Auteurs

Malik Shehadeh (M)

Medstar Washington Hospital Center, Washington, DC.

Vijaywant Brar (V)

Medstar Washington Hospital Center, Washington, DC.

John Costello (J)

Medstar Washington Hospital Center, Washington, DC.

Cyrus Hadadi (C)

Medstar Washington Hospital Center, Washington, DC.

Susan O'Donoghue (S)

Medstar Washington Hospital Center, Washington, DC.

Seth Worley (S)

Medstar Washington Hospital Center, Washington, DC.

Classifications MeSH